Cargando…
Effects of rosuvastatin/ezetimibe on senescence of CD8+ T-cell in type 2 diabetic patients with hypercholesterolemia: A study protocol
A decade ago, systemic inflammation became widely recognized as an etiology of type 2 diabetes mellitus (T2DM) and complications thereof. Senescent CD8 + T cells of T2DM patients exhibit increased secretion of pro-inflammatory cytokines and enhanced expression of cytotoxic molecules, contributing to...
Autores principales: | Ju, Sang Hyeon, Ku, Bon Jeong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9704954/ https://www.ncbi.nlm.nih.gov/pubmed/36451471 http://dx.doi.org/10.1097/MD.0000000000031691 |
Ejemplares similares
-
Effect of fixed‐dose combinations of ezetimibe plus rosuvastatin in patients with primary hypercholesterolemia: MRS‐ROZE (Multicenter Randomized Study of ROsuvastatin and eZEtimibe)
por: Kim, Kyung‐Jin, et al.
Publicado: (2016) -
Efficacy of combination of Ezetimibe 10 mg and rosuvastatin 2.5 mg versus rosuvastatin 5 mg monotherapy for hypercholesterolemia in patients with type 2 diabetes
por: Torimoto, Keiichi, et al.
Publicado: (2013) -
Association between uric acid level and incidence of albuminuria in patients with type 2 diabetes mellitus: A 4.5-year cohort study
por: Lai, Yun-Ju, et al.
Publicado: (2021) -
Mechanism of the action of bioactive proteins of vegetables in diabetes mellitus type 2: Systematic review protocol
por: de Medeiros, Amanda Fernandes, et al.
Publicado: (2019) -
Impact of lifestyle education for type 2 diabetes mellitus: Protocol for a randomized controlled trial
por: Zhu, Jingjing, et al.
Publicado: (2021)